G. Lainakis

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

Alexandros Ardavanis, Dimitrios Tryfonopoulos, A. Alexopoulos et al. · British Journal of Cancer · 2005 · 65 citations · Full text

Medicine, Oncology, Pharmacology +14

Biweekly Carboplatin/Gemcitabine in Patients with Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: Report of Efficacy, Quality of Life and Geriatric Assessment

Aristotle Bamias, G. Lainakis, Efstathios Kastritis et al. · Oncology · 2007 · 50 citations

Medicine, Oncology, Pharmacology +17

The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer

Aristotle Bamias, Efstathios Manios, Alexandra Karadimou et al. · European Journal of Cancer · 2011 · 35 citations

Medicine, Oncology, Pharmacotherapy +15

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model

Aristotelis Bamias, Alexandra Karadimou, Sofia Lampaki et al. · BMC Cancer · 2010 · 29 citations · Full text

Medicine, Oncology, Surgery +14

The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma

Anastasios Stofas, Georgia Levidou, Christina Piperi et al. · BMC Cancer · 2014 · 23 citations · Full text

Medicine, Cancer Biology, Oncology +17